Feasibility of closed-loop insulin delivery in type 2 diabetes: A randomized controlled study

Diabetes Care

Volumn 37, Issue 5, 2014, Pages 1198-1203

  Kumareswaran, Kavita ^a   Thabit, Hood ^a   Leelarathna, Lalantha ^a   Caldwell, Karen ^a   Elleri, Daniela ^a   Allen, Janet M ^a   Nodale, Marianna ^a   Wilinska, Malgorzata E ^a   Evans, Mark L ^a   Hovorka, Roman ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN LISPRO; METFORMIN; SULFONYLUREA DERIVATIVE; ANTIDIABETIC AGENT; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ALGORITHM; ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CLOSED LOOP SYSTEM; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DELIVERY DEVICE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; AGED; BLOOD; CARBOHYDRATE DIET; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; INSULIN INFUSION; METABOLISM; MIDDLE AGED; PHARMACOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ALGORITHMS; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; METFORMIN; MIDDLE AGED; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 84899089565     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1030     Document Type: Article

References (18)

1. Neubauer KM, Schaupp L, Plank J, et al. Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a hospital setting. J Diabetes Sci Tech 2013;7:402-409
2. Kumareswaran K, Evans ML, Hovorka R. Closed-loop insulin delivery: towards improved diabetes care. Discov Med 2012;13:159-170
3. Hovorka R, Canonico V, Chassin LJ, et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas 2004;25:905-920 (Pubitemid 39121173)
4. Hovorka R, Kumareswaran K, Harris J, et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ. 2011;342:d1855.
5. Kovatchev B, Cobelli C, Renard E, et al. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Tech 2010;4:1374-1381
6. Elleri D, Allen JM, Kumareswaran K, et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013;36:838-844
7. Murphy HR, Kumareswaran K, Elleri D, et al. Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care 2011;34:2527-2529
8. Yatabe T, Yamazaki R, Kitagawa H, et al. The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients. Crit Care Med 2011;39:575-578
9. Chee F, Fernando T, van Heerden PV. Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time. IEEE Trans Inf Technol Biomed 2003;7:43-53
10. Geoffrey M, Brazg R, Richard W. FreeStyle Navigator Continuous Glucose Monitoring System with TRUstart algorithm, a 1-hour warm-up time. J Diabetes Sci Tech 2011;5:99-106
11. Hovorka R, Allen JM, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-751
12. Mazor E, Averbuch A, Bar-Shalom Y, Dayan J. Interacting multiple model methods in target tracking: a survey. Aerospace and Electronic Systems. IEEE Trans Aerospace Electronic Syst 1998;34:103-123 (Pubitemid 128742265)
13. Umpierrez GE, Hellman R, Korytkowski MT, et al; Endocrine Society. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012;97:16-38
14. Iglesias P, Polini A, Muñoz A, et al. Fasting hyperglycaemia and in-hospital mortality in elderly population. Int J Clin Pract 2011;65:308-313
15. Luijf YM, Arnolds S, Avogaro A, et al. Patch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time. Diabetes Technol Ther 2013;15:575-579
16. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939
17. Ceriello A, Ihnat MA. 'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. Diabet Med 2010;27:862-867
18. Zhou J, Lv X, Mu Y, et al. The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study. Diabetes Technol Ther 2012;14:710-718